Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | CASP7 | P55210 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | EGFR | P00533 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | HTR6 | P50406 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29612371 | 1.00 | KDM4E (1.00) | KDM4EMAPTGAAALDH1A1CASP1 | |
| Hydrochloric Acid SCHEMBL1372439 | 0.98 | KDM4E (0.97) | KDM4EMAPTGAAALDH1A1CASP1 | |
| Indole SCHEMBL28345849 | 0.87 | KDM4E (0.76) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL6980983 | 0.86 | KDM4E (0.74) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL28092663 | 0.86 | MAPT (0.76) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL15281758 | 0.86 | MAPT (0.76) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL30254999 | 0.85 | ALDH1A1 (0.73) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL3382621 | 0.85 | ALDH1A1 (0.73) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL7877546 | 0.85 | MAPT (0.73) | KDM4EMAPTGAAALDH1A1CASP1 | |
| SCHEMBL20037329 | 0.84 | MAPT (0.71) | KDM4EMAPTGAAALDH1A1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974758-B | Carboxymethyl ketone compound and preparation method thereof | 生物岛实验室 | 2025-06-10 | — | — | CN | claimed |
| CN-118048666-A | Methylsulfonate type pure tin electroplating solution additive and electroplating solution containing same | 成都开华化工研究所 | 2024-05-17 | — | — | CN | claimed |
| CN-117867608-A | Neutral matte pure tin electroplating solution and preparation method thereof | 成都开华化工研究所 | 2024-04-12 | — | — | CN | claimed |
| CN-115974758-A | Carboxymethyl ketone compound and preparation method thereof | 生物岛实验室 | 2023-04-18 | — | — | CN | claimed |
| CN-113372335-B | Phenylalanine derivative containing 1,2, 4-triazole thioether as well as preparation method and application thereof | 山东大学 | 2023-02-24 | — | — | CN | claimed |
| CN-113372335-A | Phenylalanine derivative containing 1,2, 4-triazole thioether and preparation method and application thereof | 山东大学 | 2021-09-10 | — | — | CN | claimed |
| CN-103705496-B | Positively charged water-soluble prodrugs of aryl and heteroaryl propionic acids with fast skin penetration rate | 于崇曦 | 2017-03-01 | — | — | CN | claimed |
| CN-105218545-A | Kallikrein 7 micromolecular inhibitor and preparation method thereof, purposes | UNIV HENGYANG NORMAL | 2016-01-06 | — | — | CN | claimed |
| CN-104387371-A | 2-((2-methyl-3-indolyl) methyl) benzimidazole derivatives and synthesis thereof | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2015-03-04 | — | — | CN | claimed |
| CN-104204798-A | Biomarkers for bladder cancer and methods using the same | METABOLON INC | 2014-12-10 | — | — | CN | claimed |
| EP-2776832-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| EP-1310510-B1 | Topologically segregated, encoded solid phase libraries | AVENTIS PHARMA INC (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006076034-A2 | STABILIZED TWO COMPONENT SYSTEM FOR CHEMILUMIESCENT ASSAY IN IMMUNODIAGNOSTICS | BHANU, KALRA (US) | 2006-07-20 | — | — | WO | claimed |
| US-20050107258-A1 | Auxinic analogues of indole-3-acetic acid | Life Technologies Corporation | 2005-05-19 | — | — | US | claimed |
| US-20030087762-A1 | Auxinic analogues of indole-3-acetic acid | LIFE TECHNOLOGIES, INC. | 2003-05-08 | — | — | US | claimed |
| EP-0705279-B1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 2003-02-19 | — | — | EP | claimed |
| EP-4172157-B1 | CAPSID INHIBITORS FOR THE TREATMENT OF HIV | GILEAD SCIENCES INC (US) | 2025-11-19 | — | — | EP | disclosed |
| US-4322355-A | Production of 1,3-difunctional compounds | NATIONAL DISTILLERS & CHEMICAL CORP. (US) | 1982-03-30 | — | — | US | disclosed |
| US-4118395-A | Method for the production of indolyl lactones | FRANTSITS WERNER J | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087762-A1 | Auxinic analogues of indole-3-acetic acid | AADAC, AADAT, AANAT | KDM4E 2283/4885MAPT 4454/4885GAA 3723/4885 |
| US-20050107258-A1 | Auxinic analogues of indole-3-acetic acid | AADAC, AADAT, AANAT | KDM4E 2107/4885MAPT 4447/4885GAA 3903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.